Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and representative director, effective from June 2026. The decision was unanimously ...

When Julie Kim ’97 MBA graduated from the Kellogg School of Management ... You can sense this in other Kellogg graduates when you meet them out in the world.” President of Takeda Pharmaceutical ...

Weber – who was briefly chief operating officer of Takeda before rising to the CEO role and was the first non-Japanese person to lead the 243-year-old company – will be replaced by Julie Kim ...

During the latest earnings call, Takeda announced the upcoming retirement of Christophe Weber, the company’s CEO and president, who will be replaced by Mrs. Julie Kim, current president of the U ...

said Julie Kim, president of the plasma-derived therapies unit of Takeda. The group had originally aimed to begin clinical trials in July. The National Institutes of Health in the United States is ...